It is approved by the MHRA, meaning it has met the UK standards for safety, quality and effectiveness
10.1016/S2213-8587(19)30422-X Summary Keywords GLP-1 receptor agonists, diabetes, coronary artery disease, acute and chronic coronary syndromes, atherosclerosis, coronary microcirculation Citation Pahud de Mortanges A, Sinaci E, Salvador Jr D, Bally L, Muka T, Wilhelm M and Bano A (2022) GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
Before use, it needs proper reconstitution following standard lab protocols, and once mixed, it should be stored according to the compounds specific stability guidelines, usually refrigerated and shielded from light
(2018) 11(8):e007372
Neither embedded figures nor equations with special characters can be submitted, and we discourage the use of figures and equations within eLetters in general